Author:
Lopez Massimo,Giacinti Laura,Fattoruso Silvia I.S.
Reference26 articles.
1. Niederhuber JE (2004) Surgical intervention in cancer. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG (eds) Clinical Oncology, 3rd edn. Elsevier, Philadelphia, pp 579–590
2. Gill S, Loprinzi CL, Sargent DJ et al (2004) Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22:1797–1806
3. Saltz LB, Niedzwiecki D, Hollis D et al (2004) Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin (FL) in stage III colon cancer (intergroup trial CALGB C89803). Proc Am Soc Clin Oncol 22:246s
4. Van Cutsem E, Labianca R, Hossfeld G et al (2005) Randomized phase III trial comparing infused irinotecan/5-fluorouracil (5-FU)/folinic acid (IF) versus 5-FU/FA (F) in stage III colon cancer patients (PETACC 3). J Clin Oncol 23:3s
5. Andre T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343–2351